Lisa Fitzpatrick, MD, MPH, MPA, is a board-certified infectious diseases physician and a medical epidemiologist. She began her public health career in 1998 as a member of the Centers for Disease ...

Recently, the Second Circuit, Sixth Circuit, and a Texas district again rejected the pharmaceutical industry’s challenges to ...

Creating clear regulatory frameworks and reimbursement standards can help ensure the responsible and effective integration of ...

Esther S. Oh, MD, PhD, is associate professor of medicine, psychiatry and behavioral sciences, and pathology at the Johns Hopkins School of Medicine. Dr. Oh serves a ...

One way to save Medicaid money while ensuring that funds are spent to improve staffing and services is to substantially ...

Health Affairs' Rob Lott interviews Cal Chengqi Fang of the University of Chicago about his recent paper that explores how ...

The Medicare prescription drug plan redesign under the Inflation Reduction Act of 2022 aims to simplify the Part D benefit while capping out-of-pocket spending for Part D–covered drugs. Whether ...

By focusing on three priorities—one corresponding to each goal—the Center for Medicare and Medicaid Innovation’s leaders can ...

Dylan Rose Balter is an MD/MHS candidate at the Yale School of Medicine in New Haven, Connecticut.

Reducing the rates at which mothers and infants die and eliminating inequities in survival are possible only when a strategic ...

Arden Handler, DrPH, MPH, is professor emerita of community health sciences and former long-term director of the Center of Excellence in Maternal and Child Health a ...

The Executive Order represents a departure from the principles of the Constitution and Olmstead and a disregard for decades ...